© 1995 by European Society of Cardiology
Copyright © 1995, European Society of Cardiology
Molecular signalling mechanisms controlling growth and function of cardiac fibroblasts
Weis Center for Research, 26-11, Geisinger Clinic, 100 North Academy Avenue, Danville, PA 17822 USA
Cardiac fibroblasts appear to be important in producing and maintaining the extracellular matrix (ECM) of the heart. The abnormal proliferation of cardiac fibroblasts and deposition of the ECM protein, collagen, associated with hypertension and myocardial infarction, may adversely affect the performance of the heart. Several groups of factors affect collagen gene expression and/or growth of cardiac fibroblasts. Angiotensin II, aldosterone and endothelins play a central role in the remodeling of the ECM in hypertension, and decrease collagenase activity and/or increase collagen synthesis in cultured cells. Regulatory peptides that are generally elevated at sites of injury, such as TGF-β1 and PDGF, increase collagen synthesis and/or stimulate mitogenesis. Mechanical stretch enhances collagen expression and cell proliferation, responses which could in part be due to integrin activation. Cytokines may stimulate or inhibit cell growth, the latter through prostaglandin formation. Angiotensin II is a principal determinant in vivo of cardiac fibroplasia and synthesis of the ECM proteins, collagen and fibronectin. Cardiac fibroblasts possess G-protein-coupled AT1 receptors for angiotensin II that couple to activation of multiple signalling pathways, including: phospholipase C-β, with the subsequent release of Ca2+ from intracellular stores and activation of protein kinase C, mitogen-activated protein kinases, tyrosine kinases, phospholipase D, phosphatidic acid formation, and the STAT family of transcription factors. Cardiac fibroblasts respond to angiotensin II with hyperplastic/hypertrophic growth, and increased expression of collagen, fibronectin, and integrins. The mechanisms by which the AT1 receptor activates multiple signalling pathways are not known, although the receptor might interact at some level with both integrins and cytokine receptors. Different signalling pathways of the AT1 receptor may subserve different cellular responses, such as mitogenesis, ECM synthesis, or an inflammatory/stress response. Crosstalk among the signalling pathways of the AT1 receptor, and those of G-protein, cytokine, and growth-factor receptors, may determine the ultimate response of the cell.
KEYWORDS Signal transduction; Extracellular matrix; Angiotensin II; Gene expression; Cytokines; Cardiac fibroblasts
* Tel. (+1-717) 271-6815; Fax (+1-717) 271-6701. kbaker{at}SMTP.GEISINGER.edu
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  Q. Yu, R. Vazquez, E. V. Khojeini, C. Patel, R. Venkataramani, and D. F. Larson IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice Am J Physiol Heart Circ Physiol, July 1, 2009; 297(1): H76 - H85. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Inagaki, T. Koyanagi, N. C. Berry, L. Sun, and D. Mochly-Rosen Pharmacological Inhibition of {epsilon}-Protein Kinase C Attenuates Cardiac Fibrosis and Dysfunction in Hypertension-Induced Heart Failure Hypertension, June 1, 2008; 51(6): 1565 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Burstein, E. Libby, A. Calderone, and S. Nattel Differential Behaviors of Atrial Versus Ventricular Fibroblasts: A Potential Role for Platelet-Derived Growth Factor in Atrial-Ventricular Remodeling Differences Circulation, April 1, 2008; 117(13): 1630 - 1641. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Bouzegrhane and G. Thibault Is angiotensin II a proliferative factor of cardiac fibroblasts? Cardiovasc Res, February 1, 2002; 53(2): 304 - 312. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. M.C. Dixon, J. Hao, N. L. Reid, and J. C. Roth Effect of chronic AT1 receptor blockade on cardiac Smad overexpression in hereditary cardiomyopathic hamsters Cardiovasc Res, May 1, 2000; 46(2): 286 - 297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Diez and A. Simm Gene expression in rod shaped cardiac myocytes, sorted by flow cytometry Cardiovasc Res, December 1, 1998; 40(3): 530 - 537. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Shimizu, M. Yoshiyama, T. Omura, A. Hanatani, S. Kim, K. Takeuchi, H. Iwao, and J. Yoshikawa Activation of mitogen-activated protein kinases and activator protein-1 in myocardial infarction in rats Cardiovasc Res, April 1, 1998; 38(1): 116 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. van Bilsen Signal transduction revisited: recent developments in angiotensin II signaling in the cardiovascular system Cardiovasc Res, December 1, 1997; 36(3): 310 - 322. [Full Text] [PDF]
|
|
|
|
|
|
H. Ju, S. Zhao, D. S Jassal, and I. M.C Dixon Effect of AT1 receptor blockade on cardiac collagen remodeling after myocardial infarction Cardiovasc Res, August 1, 1997; 35(2): 223 - 232. [Abstract] [Full Text] [PDF]
|
|